Risperdal settlement to cost J&J $181 millionRisperdal to providers treating patients with Alzheimer's and dementia, Reuters reported. The drug, which is intended to treat schizophrenia, is not approved for these conditions.
Long-term care providers have until Friday night to submit their applications for the 2018 McKnight's Excellence in Technology Awards.
Ageless Innovation has debuted its Companion Pet Cat, the Tuxedo Cat, designed for older adults.
KCI has launched its ABTHERA ADVANCE™ Open Abdomen Dressing in the United States.